CY1121406T1 - Διαγνωση καρδιακης ανεπαρκειας - Google Patents
Διαγνωση καρδιακης ανεπαρκειαςInfo
- Publication number
- CY1121406T1 CY1121406T1 CY20191100229T CY191100229T CY1121406T1 CY 1121406 T1 CY1121406 T1 CY 1121406T1 CY 20191100229 T CY20191100229 T CY 20191100229T CY 191100229 T CY191100229 T CY 191100229T CY 1121406 T1 CY1121406 T1 CY 1121406T1
- Authority
- CY
- Cyprus
- Prior art keywords
- heart failure
- concentration
- igfbp2
- diagnosis
- patient
- Prior art date
Links
- 206010019280 Heart failures Diseases 0.000 title abstract 3
- 238000003745 diagnosis Methods 0.000 title 1
- 101001044940 Homo sapiens Insulin-like growth factor-binding protein 2 Proteins 0.000 abstract 4
- 102100022710 Insulin-like growth factor-binding protein 2 Human genes 0.000 abstract 4
- 239000008280 blood Substances 0.000 abstract 1
- 210000004369 blood Anatomy 0.000 abstract 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N27/00—Investigating or analysing materials by the use of electric, electrochemical, or magnetic means
- G01N27/26—Investigating or analysing materials by the use of electric, electrochemical, or magnetic means by investigating electrochemical variables; by using electrolysis or electrophoresis
- G01N27/416—Systems
- G01N27/447—Systems using electrophoresis
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6803—General methods of protein analysis not limited to specific proteins or families of proteins
- G01N33/6848—Methods of protein analysis involving mass spectrometry
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
- G01N2333/46—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans from vertebrates
- G01N2333/47—Assays involving proteins of known structure or function as defined in the subgroups
- G01N2333/4701—Details
- G01N2333/4745—Insulin-like growth factor binding protein
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N27/00—Investigating or analysing materials by the use of electric, electrochemical, or magnetic means
- G01N27/26—Investigating or analysing materials by the use of electric, electrochemical, or magnetic means by investigating electrochemical variables; by using electrolysis or electrophoresis
- G01N27/416—Systems
- G01N27/447—Systems using electrophoresis
- G01N27/44704—Details; Accessories
- G01N27/44717—Arrangements for investigating the separated zones, e.g. localising zones
- G01N27/4473—Arrangements for investigating the separated zones, e.g. localising zones by electric means
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/32—Cardiovascular disorders
- G01N2800/325—Heart failure or cardiac arrest, e.g. cardiomyopathy, congestive heart failure
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/50—Determining the risk of developing a disease
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Chemical & Material Sciences (AREA)
- Immunology (AREA)
- Physics & Mathematics (AREA)
- Biomedical Technology (AREA)
- Hematology (AREA)
- Urology & Nephrology (AREA)
- Analytical Chemistry (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Biotechnology (AREA)
- Cell Biology (AREA)
- Microbiology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Food Science & Technology (AREA)
- Medicinal Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Bioinformatics & Computational Biology (AREA)
- Spectroscopy & Molecular Physics (AREA)
- Biophysics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Electrochemistry (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Peptides Or Proteins (AREA)
- Other Investigation Or Analysis Of Materials By Electrical Means (AREA)
- Ultra Sonic Daignosis Equipment (AREA)
- External Artificial Organs (AREA)
- Paper (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP12305988 | 2012-08-09 | ||
| EP13747847.5A EP2883057B1 (en) | 2012-08-09 | 2013-08-09 | Diagnostic of heart failure |
| PCT/EP2013/066697 WO2014023820A1 (en) | 2012-08-09 | 2013-08-09 | Diagnostic of heart failure |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CY1121406T1 true CY1121406T1 (el) | 2020-05-29 |
Family
ID=48953397
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CY20191100229T CY1121406T1 (el) | 2012-08-09 | 2019-02-25 | Διαγνωση καρδιακης ανεπαρκειας |
Country Status (16)
| Country | Link |
|---|---|
| US (2) | US20150219669A1 (enExample) |
| EP (1) | EP2883057B1 (enExample) |
| JP (2) | JP6298054B2 (enExample) |
| CY (1) | CY1121406T1 (enExample) |
| DK (1) | DK2883057T3 (enExample) |
| ES (1) | ES2713098T3 (enExample) |
| HR (1) | HRP20190341T1 (enExample) |
| HU (1) | HUE042708T2 (enExample) |
| LT (1) | LT2883057T (enExample) |
| PL (1) | PL2883057T3 (enExample) |
| PT (1) | PT2883057T (enExample) |
| RS (1) | RS58553B1 (enExample) |
| SI (1) | SI2883057T1 (enExample) |
| SM (1) | SMT201900108T1 (enExample) |
| TR (1) | TR201902555T4 (enExample) |
| WO (1) | WO2014023820A1 (enExample) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PL3004891T3 (pl) | 2013-06-06 | 2019-09-30 | INSERM (Institut National de la Santé et de la Recherche Médicale) | Biomarker ponownej hospitalizacji po niewydolności serca |
| US11839614B2 (en) * | 2018-01-31 | 2023-12-12 | Intra-Cellular Therapies, Inc. | Methods for treating or mitigating cardiotoxicity characterized by inhibition of adenosine A2 signaling and/or adenosine A2 receptor expression |
| EP4056585A4 (en) * | 2019-11-06 | 2024-03-13 | National University Corporation Kagawa University | HEART FAILURE MARKER |
| CN120053474B (zh) * | 2025-02-26 | 2025-12-12 | 浙江大学 | 辅酶a在制备心肌细胞铁死亡抑制剂中的应用 |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20060183681A1 (en) * | 2005-02-14 | 2006-08-17 | Bio-Rad Laboratories, Inc. | Stabilized compositions containing natriuretic peptides |
| JP4465469B2 (ja) * | 2005-02-21 | 2010-05-19 | 国立大学法人佐賀大学 | 循環器病マーカーとしてのインターロイキン１３ |
| EP1722232A1 (en) | 2005-05-09 | 2006-11-15 | F.Hoffmann-La Roche Ag | Devices and methods for diagnosing or predicting early stage cardiac dysfunctions |
| US20080166734A1 (en) * | 2005-12-21 | 2008-07-10 | David Xing-Fei Deng | Genes and methods of using the same for diagnosis and for targeting the therapy of cardiovascular disease |
| JP5399900B2 (ja) * | 2006-06-30 | 2014-01-29 | メルク・シャープ・アンド・ドーム・コーポレーション | Ｉｇｆｂｐ２インヒビター |
| JP2010517023A (ja) | 2007-01-25 | 2010-05-20 | エフ．ホフマン−ラ ロシュ アーゲー | 心不全の評価におけるｉｇｆｂｐ−７の使用 |
| EP2310860A1 (en) * | 2008-07-30 | 2011-04-20 | INSERM - Institut National de la Santé et de la Recherche Médicale | Blood glutathione as a biomarker for screening asymptomatic patients at risk for heart failure |
| JP6061344B2 (ja) * | 2010-07-14 | 2017-01-18 | コモンウェルス サイエンティフィック アンド インダストリアル リサーチ オーガニゼイションＣｏｍｍｏｎｗｅａｌｔｈ Ｓｃｉｅｎｔｉｆｉｃ Ａｎｄ Ｉｎｄｕｓｔｒｉａｌ Ｒｅｓｅａｒｃｈ Ｏｒｇａｎｉｓａｔｉｏｎ | 大腸癌の診断 |
| ES2534921T3 (es) * | 2010-08-26 | 2015-04-30 | F. Hoffmann-La Roche Ag | Uso de biomarcadores en la evaluación de la transición temprana de la hipertensión arterial a la insuficiencia cardíaca |
| EP2841945A4 (en) | 2012-04-24 | 2016-04-27 | Astute Medical Inc | METHOD AND COMPOSITIONS FOR DIAGNOSIS AND FORECASTING OF STROKE OR OTHER BRAINS |
| WO2014116708A1 (en) * | 2013-01-22 | 2014-07-31 | Singulex, Inc. | Endothelin in the diagnosis of cardiac disease |
-
2013
- 2013-08-09 WO PCT/EP2013/066697 patent/WO2014023820A1/en not_active Ceased
- 2013-08-09 PT PT13747847T patent/PT2883057T/pt unknown
- 2013-08-09 DK DK13747847.5T patent/DK2883057T3/en active
- 2013-08-09 EP EP13747847.5A patent/EP2883057B1/en active Active
- 2013-08-09 HR HRP20190341TT patent/HRP20190341T1/hr unknown
- 2013-08-09 ES ES13747847T patent/ES2713098T3/es active Active
- 2013-08-09 SM SM20190108T patent/SMT201900108T1/it unknown
- 2013-08-09 JP JP2015525897A patent/JP6298054B2/ja not_active Expired - Fee Related
- 2013-08-09 TR TR2019/02555T patent/TR201902555T4/tr unknown
- 2013-08-09 PL PL13747847T patent/PL2883057T3/pl unknown
- 2013-08-09 RS RS20190247A patent/RS58553B1/sr unknown
- 2013-08-09 HU HUE13747847A patent/HUE042708T2/hu unknown
- 2013-08-09 SI SI201331364T patent/SI2883057T1/sl unknown
- 2013-08-09 LT LTEP13747847.5T patent/LT2883057T/lt unknown
- 2013-08-09 US US14/419,566 patent/US20150219669A1/en not_active Abandoned
-
2018
- 2018-01-12 US US15/869,438 patent/US11061037B2/en active Active
- 2018-02-22 JP JP2018029702A patent/JP6595641B2/ja active Active
-
2019
- 2019-02-25 CY CY20191100229T patent/CY1121406T1/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| US20180143208A1 (en) | 2018-05-24 |
| TR201902555T4 (tr) | 2019-03-21 |
| US11061037B2 (en) | 2021-07-13 |
| JP2015528562A (ja) | 2015-09-28 |
| PL2883057T3 (pl) | 2019-07-31 |
| US20150219669A1 (en) | 2015-08-06 |
| EP2883057A1 (en) | 2015-06-17 |
| EP2883057B1 (en) | 2018-12-05 |
| HUE042708T2 (hu) | 2019-07-29 |
| WO2014023820A1 (en) | 2014-02-13 |
| LT2883057T (lt) | 2019-04-25 |
| RS58553B1 (sr) | 2019-05-31 |
| JP2018109640A (ja) | 2018-07-12 |
| JP6298054B2 (ja) | 2018-03-20 |
| ES2713098T3 (es) | 2019-05-17 |
| PT2883057T (pt) | 2019-03-06 |
| HRP20190341T1 (hr) | 2019-05-31 |
| DK2883057T3 (en) | 2019-03-18 |
| JP6595641B2 (ja) | 2019-10-23 |
| SI2883057T1 (sl) | 2019-07-31 |
| SMT201900108T1 (it) | 2019-05-10 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CY1121406T1 (el) | Διαγνωση καρδιακης ανεπαρκειας | |
| MX362514B (es) | Kits y ensayos de diagnostico para la deteccion del receptor 1 de folato. | |
| TR201906285T4 (tr) | İntraoperatif otolog kan kurtarımından tümör hücrelerinin giderilmesi. | |
| MX2017014381A (es) | Metodos terapeuticos y diagnosticos para cancer. | |
| BR112013010015A2 (pt) | aparelho e método para detecção não invasiva de doenças que afetam as propriedades estruturais em tecidos biológicos | |
| MX2016006252A (es) | Tratamiento o prevencion de afecciones pulmonares con monoxido de carbono. | |
| EA201391587A1 (ru) | Комбинированная терапия на основе hsp90 | |
| EP3236262A3 (en) | Surrogate functional diagnostics test for cancer | |
| EA201391216A1 (ru) | Способ и установка для контроля лечения пациента, предпочтительно для контроля гемодиализа, гемодиафильтрации и/или перитонеального диализа | |
| MX368099B (es) | Biomarcadores para predecir y evaluar el grado de respuesta de sujetos con cancer de endometrio a compuestos de tipo lenvatinib. | |
| CY1121916T1 (el) | Βιοδεικτες micro-rna για την ταυτοποιηση του κινδυνου και/ή τη διαγνωση του ογκου στον πνευμονα | |
| MX386919B (es) | Composiciones, métodos y kits para el diagnóstico de una neoplasia neuroendocrina gastroenteropancreática. | |
| CY1122360T1 (el) | Μεθοδος για τη διαγνωση της νοσου niemann-pick | |
| EA201490883A1 (ru) | ПРИМЕНЕНИЕ АНТИТЕЛА К α-СИНУКЛЕИНУ ДЛЯ ДИАГНОСТИКИ ПОВЫШЕННОГО УРОВНЯ α-СИНУКЛЕИНА В МОЗГЕ | |
| BR112018011224A2 (pt) | processo de avaliação do risco de complicações nos pacientes que apresentam uma síndrome da resposta inflamatória sistêmica (sirs) | |
| CY1122033T1 (el) | Μεθοδοι για την αυξηση του βιaιa εκπνεομενου ογκου σε ασθματικους με τη χρηση μπενραλιζουμαμπης | |
| RU2013138721A (ru) | Способы и наборы для прогнозирования риска дыхательной недостаточности, почечной недостаточности или тромбопении у пациента, страдающего сепсисом, путем измерения уровней эндокана в крови | |
| EA201690537A1 (ru) | Способы и средства для введения контрастной среды | |
| CY1120063T1 (el) | Αντισωματα κατα του ανθρωπινου dlk-1 που εχει δραση κατα των ογκων in vivo | |
| CY1119653T1 (el) | Μεθοδος για ταυτοποιηση της ευαισθησιας ενος ασθενους σε θεραπεια αναστολης της τελομερασης | |
| CY1122202T1 (el) | Προσδιορισμος κινδυνου για θεραπεια αντιβιοτικων σε ασθενεις οι οποιοι υποφερουν απο πρωτοπαθη μη μολυσματικη νοσο δια καθορισμου του επιπεδου προκαλσιτονινης | |
| MX2015001788A (es) | Metabolitos de metionina predicen la evolución agresiva del cáncer. | |
| EA201491780A1 (ru) | Мутанты c-raf, придающие резистентность к ингибиторам raf | |
| CY1121748T1 (el) | Βιοδεικτης επανανοσηλειας μετα απο καρδιακη ανεπαρκεια | |
| WO2014042148A8 (ja) | がんマーカーおよびその用途 |